A citation-based method for searching scientific literature

Christopher P Cannon, Eugene Braunwald, Carolyn H McCabe, Daniel J Rader, Jean L Rouleau, Rene Belder, Steven V Joyal, Karen A Hill, Marc A Pfeffer, Allan M Skene. N Engl J Med 2004
Times Cited: 3445



John C LaRosa, Scott M Grundy, David D Waters, Charles Shear, Philip Barter, Jean-Charles Fruchart, Antonio M Gotto, Heiner Greten, John J P Kastelein, James Shepherd, Nanette K Wenger. N Engl J Med 2005
Times Cited: 2441




List of shared articles



Times cited

Alirocumab after acute coronary syndrome in patients with a history of heart failure.
Harvey D White, Gregory G Schwartz, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Chern-En Chiang, Rafael Diaz, Shaun G Goodman, Johan Wouter Jukema, Megan Loy,[...]. Eur Heart J 2022
3

LDL como objetivo terapéutico.
Ángel Díaz Rodríguez, Teresa Mantilla Morató. Clin Investig Arterioscler 2022
0

Achievement of LDL-Cholesterol Goals after Acute Myocardial Infarction: Real-World Data from the City of Curitiba Public Health System.
André Bernardi, Marcia Olandoski, Lucas Olandoski Erbano, Luiz Cesar Guarita-Souza, Cristina Pellegrino Baena, José Rocha Faria-Neto. Arq Bras Cardiol 2022
1

Undertreatment or Overtreatment With Statins: Where Are We?
Irene García-Fernández-Bravo, Ana Torres-Do-Rego, Antonio López-Farré, Francisco Galeano-Valle, Pablo Demelo-Rodriguez, Luis A Alvarez-Sala-Walther. Front Cardiovasc Med 2022
0

Effect of Omega-3 Fatty Acids on Coronary Plaque Morphology - A Serial Computed Tomography Angiography Study.
Sadako Motoyama, Yasuomi Nagahara, Masayoshi Sarai, Hideki Kawai, Keiichi Miyajima, Yoshihiro Sato, Ryota Matsumoto, Hiroshi Takahashi, Hiroyuki Naruse, Junnichi Ishii,[...]. Circ J 2022
3


Contemporary Management of Dyslipidemia.
Richard A Ferraro, Thorsten Leucker, Seth S Martin, Maciej Banach, Steven R Jones, Peter P Toth. Drugs 2022
1

Lipid-Targeted Atherosclerotic Risk Reduction in Older Adults: A Review.
Lauren J Hassen, Steven R Scarfone, Michael Wesley Milks. Geriatrics (Basel) 2022
0

Emerging views of statin pleiotropy and cholesterol lowering.
Dongbo Yu, James K Liao. Cardiovasc Res 2022
12

Intravascular imaging assessment of pharmacotherapies targeting atherosclerosis: advantages and limitations in predicting their prognostic implications.
Vincenzo Tufaro, Patrick W Serruys, Lorenz Räber, Martin R Bennett, Ryo Torii, Sophie Z Gu, Yoshinobu Onuma, Anthony Mathur, Andreas Baumbach, Christos Bourantas. Cardiovasc Res 2022
0

Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
Jiaxi Zhu, Yunpeng Zhu, Minlu Zhang, Qing Xue, Junlong Hu, Hao Liu, Rui Wang, Xiaowei Wang, Qiang Zhao. J Thorac Cardiovasc Surg 2022
2

Prevalence of statin intolerance: a meta-analysis.
Ibadete Bytyçi, Peter E Penson, Dimitri P Mikhailidis, Nathan D Wong, Adrian V Hernandez, Amirhossein Sahebkar, Paul D Thompson, Mohsen Mazidi, Jacek Rysz, Daniel Pella,[...]. Eur Heart J 2022
9

Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care.
Barbara S Wiggins, James M Backes, Daniel Hilleman. Pharmacotherapy 2022
0



A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using Real-world Data.
Alaa Rahhal, Fadi Khir, Bassant Orabi, Salma Chbib, Osama Al-Khalaila, Mohamed Salah Abdelghani, Omnia Osman, Amr Azzam Ashour, Mohammad Al-Awad, Ahmed Mahfouz,[...]. Curr Probl Cardiol 2022
0

High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.
Adam J Nelson, Kevin Haynes, Sonali Shambhu, Zubin Eapen, Mark J Cziraky, Michael G Nanna, Sara B Calvert, Kerrin Gallagher, Neha J Pagidipati, Christopher B Granger. J Am Coll Cardiol 2022
2

Room for improvement: initiation of lipid-lowering treatment and achievement of lipid target levels-a Danish registry-based study.
Sofie A Rerup, Rasmus Rørth, Lia E Bang, Ulrik M Mogensen, Christian Torp-Pedersen, Gunnar Gislason, Lars Køber, Emil L Fosbøl. Eur Heart J Qual Care Clin Outcomes 2021
0

Impact of high-dose statin on cardiovascular outcomes in real-world patients with ST-elevation acute myocardial infarction.
Takenobu Shimada, Kohei Osakada, Koya Okabe, Yuki Shima, Haruki Eguchi, Seiji Habara, Takeshi Tada, Yuya Taguchi, Akihiro Ikuta, Makoto Takamatsu,[...]. Heart Vessels 2021
2

Pharmacological Management of Hyperlipidemia in Older individuals.
Laura V Tsu, Kacey Carroll, Katee Kindler, Nicole Early. Sr Care Pharm 2021
0

Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study.
Michal Vrablik, Bohumil Seifert, Alexander Parkhomenko, Maciej Banach, Jacek J Jóźwiak, Robert Gabor Kiss, Dan Gaita, Katarina Rašlová, Marie Zachlederova, Sarah Bray,[...]. Atherosclerosis 2021
3

Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study.
Juwon Kim, Danbee Kang, Hyejeong Park, Minwoong Kang, Ki Hong Choi, Taek Kyu Park, Joo Myung Lee, Jeong Hoon Yang, Young Bin Song, Jin-Ho Choi,[...]. Cardiovasc Drugs Ther 2021
0

Multi-modality intravascular imaging for guiding coronary intervention and assessing coronary atheroma: the Novasight Hybrid IVUS-OCT system.
Retesh Bajaj, Hector M Garcia-Garcia, Brian K Courtney, Anantharaman Ramasamy, Vincenzo Tufaro, Emrah Erdogan, Ameer H Khan, Natasha Alves, Krishnaraj S Rathod, Yoshinobu Onuma,[...]. Minerva Cardiol Angiol 2021
2

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
Christopher P Cannon, James A de Lemos, Robert S Rosenson, Christie M Ballantyne, Yuyin Liu, Qi Gao, Tamara Palagashvilli, Shushama Alam, Katherine E Mues, Deepak L Bhatt,[...]. JAMA Cardiol 2021
8

Repeated In-Stent Restenosis Despite Aggressive Lipid Loweringby PCSK-9 Inhibitor Treatment: A Case Report.
Yutaka Yonezawa, Masashi Sakuma, Shichiro Abe, Ikuko Shibasaki, Shigeru Toyoda, Teruo Inoue. Tohoku J Exp Med 2021
1